Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MTSR is expected to report earnings to rise 22.73% to -81 cents per share on December 03
Q3'25
Est.
$-0.81
Q2'25
Missed
by $0.03
The last earnings report on July 28 showed earnings per share of -66 cents, missing the estimate of -62 cents. With 1.51M shares outstanding, the current market capitalization sits at 3.77B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MTSR showed earnings on July 28, 2025. You can read more about the earnings report here.